Francisco X. Real

Research interests

Publications

• A faecal microbiota signature with high specificity for pancreatic cancer

  Gut · 2022 · https://doi.org/10.1136/gutjnl-2021-324755

• An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

  Nature Communications · 2021 · https://doi.org/10.1038/s41467-021-22465-w

• Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

  Nature Communications · 2018 · https://doi.org/10.1038/s41467-018-02942-5

• Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations

  Gut · 2017 · https://doi.org/10.1136/gutjnl-2017-314828

• A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns

  Nature · 2016 · https://doi.org/10.1038/nature19823

• Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

  Cancer Cell · 2016 · https://doi.org/10.1016/j.ccell.2016.05.004

• GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer

  Gut · 2016 · https://doi.org/10.1136/gutjnl-2015-311256

• Addressing the challenges of pancreatic cancer: Future directions for improving outcomes

  Pancreatology · 2014 · https://doi.org/10.1016/j.pan.2014.10.001

• Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

  Nature Genetics · 2014 · https://doi.org/10.1038/ng.3052

• Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy

  Nature Genetics · 2013 · https://doi.org/10.1038/ng.2799

• Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome

  European Urology · 2013 · https://doi.org/10.1016/j.eururo.2013.08.052

• A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

  Nature Genetics · 2010 · https://doi.org/10.1038/ng.687

• Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas

  Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2005.05.1771

• Bladder Cancer and Exposure to Water Disinfection By-Products through Ingestion, Bathing, Showering, and Swimming in Pools

  American Journal of Epidemiology · 2006 · https://doi.org/10.1093/aje/kwj364

• P53 as a prognostic marker for bladder cancer: a meta-analysis and review

  The Lancet Oncology · 2005 · https://doi.org/10.1016/s1470-2045(05)70315-6

• NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses

  The Lancet · 2005 · https://doi.org/10.1016/s0140-6736(05)67137-1

• Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

  Journal of Clinical Oncology · 1997 · https://doi.org/10.1200/jco.1997.15.8.2866

Current projects

No projects listed.